We are monitoring the impact of COVID-19 on MEA Point Of Care Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1485
Share on
Share on

Middle East & Africa Point of Care (POC) Diagnostics/Testing Market Research Report – Segmented By Product, End-User, Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Size, Share, Trends, Growth Opportunities Assessment, Industry Forecast | 2021 to 2026

Pulished: April, 2021
ID: 1485
Pages: 135

MEA Point of Care (POC) Diagnostics/Testing Market Size (2021 to 2026)

The size of the Point of Care (POC) Diagnostics/Testing Market in the Middle East & Africa was worth USD 1.99 billion in 2021 and estimated to reach USD 3.12 billion by the end of 2026 with a CAGR of 9.42%.

Point-of-care diagnostics allow a speedy, convenient, and cost-efficient way to diagnose diseases at healthcare centres and hospitals. As compared to conventional in-laboratory tests, point-of-care diagnostics have the advantage of speed and convenience without compromising on consistency. The speed factor, especially, is the greatest attribute of point-of-care diagnostics, because faster diagnosis facilitates faster patient management. Point-of-care diagnostics help cut down on the need for sophisticated diagnostic systems for regular tests like blood tests and urine tests.

Many advanced points of care diagnostic products are on the verge of being used practically and widely. But, more than innovative and advanced point-of-care devices, there is a great need for inexpensive solutions that can be set up in regions where infectious diseases are highly prevalent. In developing areas, these tests are crucial in counterbalancing the lack of adequate laboratory capacity. It is one of the most promising opportunities that can be grabbed by market players.

Clinics and other healthcare establishments, to provide useful and fast diagnostic results, are opting for the point-of-care test, which is consequently influencing industrial growth. Advances in technology and the introduction of cost-effective and high-quality medical solutions aimed at achieving miniaturization and lab automation are expected to serve the point-of-care diagnostics market as a vital driver. Moreover, rising levels of patient awareness are expected to play a crucial role behind the growth because patients, particularly the ones suffering from long-term diseases such as diabetes, are actively participating in the shift relating to the implementation of point-of-care diagnostic practices. Additionally, healthcare practitioners have been observed to be increasingly more open and willing to adopt the use of point-of-care diagnostic consumables and medical devices, thereby resulting in rapid demand and growth of this market.

However, there are some certain market restraints that players need to overcome. Reluctance from the industry towards changing the existing norms, many products recalls, stringent regulatory framework and unfavourable reimbursement scenario are some of the challenges faced by the point-of-care diagnostics market.

This market research report has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.

  • By Product: Infectious Diseases, Cardiac Markers, Oncology Markers, OTC Diagnostic Tests, drugs of abuse, Blood Gas Testing, Fertility Testing, Urinalysis, Coagulation, Hematology, Glucose Monitoring, Ambulatory Chemistry & Decentralized Clinical Chemistry
  • By End-User: Clinics, Hospitals, Home Healthcare, Ambulatory Care Settings & laboratories
  • By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Regionally, emerging markets high growth potential for companies involved in the development and distribution of point-of-care diagnostic devices. Increasing initiatives by market players, growing patient population base, and rise in the number of partnerships and joint ventures among point-of-care providers are the key factors driving the growth of point-of-care diagnostics market in emerging countries.

Companies like Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., and PTS Diagnostics are playing a pivotal role in the MEA Point of Care (POC) Diagnostics/Testing Market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Infectious Diseases             

                                5.1.3 Cardiac Markers   

                                5.1.4 Oncology Markers

                                5.1.5 OTC Diagnostic Tests          

                                5.1.6 Drugs Of Abuse    

                                5.1.7 Blood Gas Testing

                                5.1.8 Fertility Testing     

                                5.1.9 Urinalysis 

                                5.1.10 Coagulation         

                                5.1.11 Hematology         

                                5.1.12 Glucose Monitoring          

                                5.1.13 Ambulatory Chemistry    

                                5.1.14 Decentralized Clinical Chemistry 

                                5.1.15 Others   

                                5.1.16 Y-o-Y Growth Analysis, By Product              

                                5.1.17 Market Attractiveness Analysis, By Product            

                                5.1.18 Market Share Analysis, By Product             

                5.2 End-Users                   

                                5.2.1 Introduction           

                                5.2.2 Clinics        

                                5.2.3 Hospitals  

                                5.2.4 Home Healthcare 

                                5.2.5 Ambulatory Care Settings 

                                5.2.6 Laboratories           

                                5.2.7 Others      

                                5.2.8 Y-o-Y Growth Analysis, By End-Users           

                                5.2.9 Market Attractiveness Analysis, By End-Users          

                                5.2.10 Market Share Analysis, By End-Users        

                5.3 Mode of Delivery                     

                                5.3.1 Introduction           

                                5.3.2 OTC            

                                5.3.3 Prescription            

                                5.3.4 Y-o-Y Growth Analysis, By Mode of Delivery             

                                5.3.5 Market Attractiveness Analysis, By Mode of Delivery            

                                5.3.6 Market Share Analysis, By Mode of Delivery             

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By End-Users

                                                6.1.3.4 By Mode of Delivery

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By End-Users

                                                6.1.4.4 By Mode of Delivery

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By End-Users

                                                6.1.5.4 By Mode of Delivery

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation                             

                8.3 Roche Diagnostics                    

                8.4 BioMerieux                

                8.5 Siemens Healthcare                

                8.6 Beckman Coulter                     

                8.7 Becton Dickinson and Company                        

                8.8 Johnson & Johnson                 

                8.9 Johnson & Johnson                 

                8.10 PTS Diagnostics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Middle East & Africa Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  2. Middle East & Africa Infectious Diseases Market By Region, From 2021 to 2026 (USD Billion)
  3. Middle East & Africa Cardiac Markers Market By Region, From 2021 to 2026 (USD Billion)
  4. Middle East & Africa Oncology Markers Market By Region, From 2021 to 2026 (USD Billion)
  5. Middle East & Africa OTC Diagnostic Tests Market By Region, From 2021 to 2026 (USD Billion)
  6. Middle East & Africa Drugs Of Abuse Market By Region, From 2021 to 2026 (USD Billion)
  7. Middle East & Africa Blood Gas Testing Market By Region, From 2021 to 2026 (USD Billion)
  8. Middle East & Africa Fertility Testing Market By Region, From 2021 to 2026 (USD Billion)
  9. Middle East & Africa Urinalysis Market By Region, From 2021 to 2026 (USD Billion)
  10. Middle East & Africa Coagulation Market By Region, From 2021 to 2026 (USD Billion)
  11. Middle East & Africa Hematology Market By Region, From 2021 to 2026 (USD Billion)
  12. Middle East & Africa Glucose Monitoring Market By Region, From 2021 to 2026 (USD Billion)
  13. Middle East & Africa Ambulatory Chemistry Market By Region, From 2021 to 2026 (USD Billion)
  14. Middle East & Africa Decentralized Clinical Chemistry Market By Region, From 2021 to 2026 (USD Billion)
  15. Middle East & Africa Others Market By Region, From 2021 to 2026 (USD Billion)
  16. Middle East & Africa Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  17. Middle East & Africa Clinics Market By Region, From 2021 to 2026 (USD Billion)
  18. Middle East & Africa Hospitals Market By Region, From 2021 to 2026 (USD Billion)
  19. Middle East & Africa Home Healthcare Market By Region, From 2021 to 2026 (USD Billion)
  20. Middle East & Africa Ambulatory Care Settings Market By Region, From 2021 to 2026 (USD Billion)
  21. Middle East & Africa Laboratories Market By Region, From 2021 to 2026 (USD Billion)
  22. Middle East & Africa Others Market By Region, From 2021 to 2026 (USD Billion)
  23. Middle East & Africa Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  24. Middle East & Africa OTC Market By Region, From 2021 to 2026 (USD Billion)
  25. Middle East & Africa Prescription Market By Region, From 2021 to 2026 (USD Billion)
  26. Middle East Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  27. Middle East Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  28. Middle East Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)
  29. Africa Point-of-Care Diagnostics Market By Application, From 2021 to 2026 (USD Billion)
  30. Africa Point-of-Care Diagnostics Market By End-Users, From 2021 to 2026 (USD Billion)
  31. Africa Point-of-Care Diagnostics Market By Mode of Delivery, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample